Ethics: Genetic testing for MEN1—whose responsibility?

[1]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[2]  T. Links,et al.  Recent results of basic and clinical research in MEN1: opportunities to improve early detection and treatment , 2012, Expert review of endocrinology & metabolism.

[3]  Á. Mendes,et al.  Families’ experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk population , 2012, Familial Cancer.

[4]  T. File,et al.  Improving clinical practice guidelines--the answer is more clinical research. , 2011, Archives of internal medicine.

[5]  Ian Bullock,et al.  A Summary of the Methods That the National Clinical Guideline Centre Uses to Produce Clinical Guidelines for the National Institute for Health and Clinical Excellence , 2011, Annals of Internal Medicine.

[6]  David M. Eddy,et al.  Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs , 2011, Annals of Internal Medicine.

[7]  M. Parker,et al.  Confidentiality and sharing genetic information with relatives , 2010, The Lancet.

[8]  D. Amor,et al.  Increased genetic counseling support improves communication of genetic information in families , 2008, Genetics in Medicine.

[9]  G. Suthers,et al.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder , 2005, Journal of Medical Genetics.

[10]  T. van Vroonhoven,et al.  Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.